Chitosan-glycolipid hybrid nanogels
|
Fucoxanthin |
The bioavailability of fucoxanthin from chitosan-glycolipid hybrid nanogels was the highest compared to chitosan nanogels without glycolipid, mixture of fucoxanthin with glycolipid and control groups. Enhanced stability and bioavailability by nanoencapsulation. |
[120] |
The low cell viability significantly at nanoencapsulated fucoxanthin compared to without using glycolipid and induced apoptosis in Caco-2 cells and suppressed ROS production. |
[121] |
PEG biodegradable coated nanoparticles
|
Approximately 82% fucoxanthin encapsulation and a higher antioxidant activity significantly than sunflower oil and trolox. |
[122] |
Casein nanoparticles and chitosan-coated nanoparticles
|
Increased retention and adsorption and two-fold higher absorption to the blood circulation than non-coated nanoparticles. |
[110] |
Potato protein-based polymeric nanoparticles
|
Astaxanthin |
~80% simulated gastric and intestinal digestion and 11 times higher bioavailability compared to unencapsulated astaxanthin. |
[122] |